M Raymond V Finlay

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 7

Top Venues

Journal of medicinal chemistry

Nature communications

Molecular cancer therapeutics

ACS medicinal chemistry letters

This page only lists publications with an associated author ORCID identifier.

Publications

M Raymond V Finlay, Mark Anderton, Andrew Bailey, Scott Boyd, Joanna Brookfield, Ceri Cairnduff, Mark D Charles, Anne Cheasty, Susan E Critchlow, Janet Culshaw, Judit Debreczeni, Tennyson Ekwuru, Ian Hollingsworth, Neil Jones, Fred Leroux, Mairi Littleson, Hollie McCarron, Jennifer McKelvie, Lorraine Mooney, J Willem M Nissink, Joe Patel, David Perkins, Steve Powell, Mar Jimenez Quesada, Piotr Raubo, Verity Sabin, James Smith, Peter D Smith, Andrew Stark, Attilla K T Ting, Peng Wang, Zena Wilson, Jon J Winter-Holt, J Matthew Wood, Gail L Wrigley, Guoqing Yu, Peng Zhang
Correction to "Discovery of a Thiadiazole-Pyridazine-Based Allosteric Glutaminase 1 Inhibitor Series That Demonstrates Oral Bioavailability and Activity in Tumor Xenograft Models". Journal of medicinal chemistry (2023)
Aatman S Doshi, Susan Cantin, Marylens Hernandez, Srimathi Srinivasan, Sharon Tentarelli, Matthew Griffin, Yanjun Wang, Petar Pop-Damkov, Laura B Prickett, Cecilia Kankkonen, Minhui Shen, Maryann San Martin, Song Wu, M Paola Castaldi, Hormas Ghadially, Jeffrey Varnes, Sonya Gales, David Henry, Clare Hoover, Deanna A Mele, Iain Simpson, Eric T Gangl, Scott N Mlynarski, M Raymond V Finlay, Lisa Drew, Stephen E Fawell, Wenlin Shao, Alwin G Schuller
Novel arginase inhibitor, AZD0011, demonstrates immune cell stimulation and anti-tumor efficacy with diverse combination partners. Molecular cancer therapeutics (2023)
Frederick W Goldberg, Attilla K T Ting, David Beattie, Gillian M Lamont, Charlene Fallan, M Raymond V Finlay, Beth Williamson, Marianne Schimpl, Alexander R Harmer, Oladipupo B Adeyemi, Pär Nordell, Anna S Cronin, Mercedes Vazquez-Chantada, Derek Barratt, Antonio Ramos-Montoya, Elaine B Cadogan, Barry R Davies
Optimization of hERG and Pharmacokinetic Properties for Basic Dihydro-8 H -purin-8-one Inhibitors of DNA-PK. ACS medicinal chemistry letters 13 (8) (2022)
M Raymond V Finlay, Peter Barton, Sue Bickerton, Michal Bista, Nicola Colclough, Darren A E Cross, Laura Evans, Nicolas Floc'h, Clare Gregson, Carine M Guérot, David Hargreaves, Xiaoming Kang, Eva M Lenz, Xu Li, Yi Liu, Olivier Lorthioir, Matthew J Martin, Darren McKerrecher, Claire McWhirter, Daniel O'Neill, Jonathan P Orme, Arash Mosallanejad, Amar Rahi, Paul D Smith, Verity Talbot, Richard A Ward, Gail Wrigley, Marta Wylot, Lin Xue, Tieguang Yao, Yang Ye, Xiliang Zhao
Potent and Selective Inhibitors of the Epidermal Growth Factor Receptor to Overcome C797S-Mediated Resistance. Journal of medicinal chemistry 64 (18) (2021)
Frederick W Goldberg, M Raymond V Finlay, Attilla K T Ting, David Beattie, Gillian M Lamont, Charlene Fallan, Gail L Wrigley, Marianne Schimpl, Martin R Howard, Beth Williamson, Mercedes Vazquez-Chantada, Derek G Barratt, Barry R Davies, Elaine B Cadogan, Antonio Ramos-Montoya, Emma Dean
The Discovery of 7-Methyl-2-[(7-methyl[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino]-9-(tetrahydro-2H-pyran-4-yl)-7,9-dihydro-8H-purin-8-one (AZD7648), a Potent and Selective DNA-Dependent Protein Kinase (DNA-PK) Inhibitor. Journal of medicinal chemistry 63 (7) (2020)
M Raymond V Finlay, Mark Anderton, Andrew Bailey, Scott Boyd, Joanna Brookfield, Ceri Cairnduff, Mark Charles, Anne Cheasty, Susan E Critchlow, Janet Culshaw, Tennyson Ekwuru, Ian Hollingsworth, Neil Jones, Fred Leroux, Mairi Littleson, Hollie McCarron, Jennifer McKelvie, Lorraine Mooney, J Willem M Nissink, David Perkins, Steve Powell, Mar Jimenez Quesada, Piotr Raubo, Verity Sabin, James Smith, Peter D Smith, Andrew Stark, Attilla Ting, Peng Wang, Zena Wilson, Jon J Winter-Holt, J Matthew Wood, Gail L Wrigley, Guoqing Yu, Peng Zhang
Discovery of a Thiadiazole-Pyridazine-Based Allosteric Glutaminase 1 Inhibitor Series That Demonstrates Oral Bioavailability and Activity in Tumor Xenograft Models. Journal of medicinal chemistry 62 (14) (2019)
Jacqueline H L Fok, Antonio Ramos-Montoya, Mercedes Vazquez-Chantada, Paul W G Wijnhoven, Valeria Follia, Neil James, Paul M Farrington, Ankur Karmokar, Sophie E Willis, Jonathan Cairns, Jenni Nikkilä, David Beattie, Gillian M Lamont, M Raymond V Finlay, Joanne Wilson, Aaron Smith, Lenka Oplustil O'Connor, Stephanie Ling, Stephen E Fawell, Mark J O'Connor, Simon J Hollingsworth, Emma Dean, Frederick W Goldberg, Barry R Davies, Elaine B Cadogan
AZD7648 is a potent and selective DNA-PK inhibitor that enhances radiation, chemotherapy and olaparib activity. Nature communications 10 (1) (2019)

M Raymond V Finlay.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

M Raymond V Finlay